OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
November 30, 2015
As 3-D screening and lab automation improve lead optimization, open collaborative models are breaking down long-established walls. Will the industry redefine the way it handles R&D?
November 26, 2015
Ash Stevens has received FDA’s approval to manufacture Takeda’s multiple myeloma drug, ixazomib, at its facility in Riverview, Michigan.
November 23, 2015
The University of Sheffield has appointed Cobra Biologics to advance novel fusion protein technology into Phase 1 clinical trials.
November 20, 2015
Expansions at Catalent’s Kansas City, MO, and Madison, WI facilities made in response to industry demand.
November 17, 2015
Operations at Catalent’s Beinheim, France, softgel facility were suspended following suspected deliberate action to misplace capsules.
November 10, 2015
The UK’s National Biologics Manufacturing Centre will use Novasep’s BioSC Lab for protein purification.
Industry veteran Mark Kontny joins board of directors at Grand River Aseptic Manufacturing.
November 05, 2015
Biotech boom, niche markets, smaller batch sizes and high potency manufacturing are among the key trends shaping the pharmaceutical industry of the 21st century, according to Christian Treitel from Bosch Packaging Technology.
November 02, 2015
Better process development is creating industry benchmarks for bioprocessing.
While biologics development grabs investor interest, small-molecule APIs still hold two-thirds of the drug-development pipeline.